Healthcare expenses in the United States are rising faster than ever, putting American workers under increasing financial pressure. In 2026, employer-sponsored insurance premiums are expected to climb by nearly 10%, the largest jump in over a decade. Meanwhile, many individuals enrolled in Affordable Care Act plans could face premium increases exceeding 75% as temporary pandemic-era subsidies come to an end.
The Role of Insurers
Health insurance companies, such as UnitedHealth Group, Cigna, and CVS Health, are playing a major role in driving up costs. By managing pharmacy benefits and negotiating drug prices, these companies influence how much patients and employers pay. Practices like favoring high-rebate medications and exclusive contracts have been linked to rising drug prices, and federal regulators have scrutinized insurers for potential anti-competitive behavior.
High Drug Prices Add to the Burden
Pharmaceutical companies contribute significantly to the surge in costs. Drugs like GLP-1 treatments for weight management and diabetes can cost patients up to $1,000 per month. While these medications offer essential health benefits, their high prices, along with the development of new cancer therapies, are major factors behind the escalating expenses in the healthcare system.
Employers’ Influence on Coverage
Employers, who provide insurance to more than 150 million Americans, also shape the cost landscape. To manage rising expenses, many companies increase premiums, deductibles, and copays or shift employees to high-deductible plans. Some have reduced coverage or benefits altogether, transferring more financial responsibility to workers.
Looking Ahead
The rapid increase in healthcare costs is a multifaceted problem, driven by insurers, drug makers, and employers alike. Workers bear the brunt of these rising expenses, highlighting the need for systemic solutions to make healthcare more affordable and sustainable for Americans.
